Managed Care No Panacea

20 February 1995

Managed care is no panacea for slowing the rise in the cost of Medicare, Health Care Finance Administration head Bruce Vladek told the House Ways and Means subcommittee on health. Current reimbursement formulas mean that Medicare pays too much for recipients' choosing managed care, he said, because the health plans attract the healthier members of the Medicare population.

The subcommittee ended a week of hearings on Medicare by focusing on encouraging the elderly to join Health Maintenance Organizations and other forms of managed care, in an effort to hold down a projected annual rate of 9.1% in health care spending over the next five years.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight